Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Ass'n for Molecular Pathology (1)
- BRCA 1 (1)
- BRCA 2 (1)
- Biotechnology (1)
- Diamond v. Chakrabarty (1)
-
- Erlotinib (1)
- FDA (1)
- Federal Circuit (1)
- Gene Patents (1)
- Genetic engineering (1)
- Genome Sequencing (1)
- IVCDD (1)
- IVD (1)
- Intellectual property (1)
- Licensing (1)
- Mayo Collaborative Services (1)
- Myriad Genetics (1)
- Myriad I (1)
- Myriad II (1)
- Precision medicine (1)
- Prometheus Laboratories (1)
- Surrogate licensing (1)
Articles 1 - 3 of 3
Full-Text Articles in Intellectual Property Law
Intellectual Property, Surrogate Licensing, And Precision Medicine, Jacob S. Sherkow, Jorge L. Contreras
Intellectual Property, Surrogate Licensing, And Precision Medicine, Jacob S. Sherkow, Jorge L. Contreras
IP Theory
The fruits of the biotechnology revolution are beginning to be harvested. Recent regulatory approvals of a variety of advanced therapies—Keytruda (pembrolizumab), Kymriah (tisagenlecleucel), and patisiran—have ushered in an age of “precision medicine” treatments that target patients’ specific genetic, physiological, and environmental profiles rather than generalized diagnoses of disease. Therapies like these may soon be supplemented by gene editing technologies such as CRISPR, which could enable the targeted eradication of deleterious genetic variants to improve human health. But the intellectual property (IP) surrounding precision therapies and their foundational technology remain controversial. Precision therapies ultimately rely—and are roughly congruent with—basic scientific information …
Will Gene Patents Impede Whole Genome Sequencing?: Deconstructing The Myth That 20% Of The Human Genome Is Patented, Christopher M. Holman
Will Gene Patents Impede Whole Genome Sequencing?: Deconstructing The Myth That 20% Of The Human Genome Is Patented, Christopher M. Holman
IP Theory
No abstract provided.
A Thousand Tiny Pieces: The Federal Circuit’S Fractured Myriad Ruling, Lessons To Be Learned, And The Way Forward, Jonathan R. K. Stroud
A Thousand Tiny Pieces: The Federal Circuit’S Fractured Myriad Ruling, Lessons To Be Learned, And The Way Forward, Jonathan R. K. Stroud
IP Theory
No abstract provided.